Company: EVGN
Filing Date: 2025-06-05
Form Type: 6-K
Source: 0001178913-25-002109
Chunk: 0

Company: Evogene Ltd.
Filing Date: 2025-06-05
Form: 6-K
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-36187 EVOGENE LTD. (Translation of Registrant’s Name into English) 13 Gad Feinstein Street, Park Rehovot, Rehovot 7638517, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒Form 40-F ☐ CONTENTS Evogene Ltd., or Evogene, reports the following changes in the management of its subsidiary, Biomica Ltd., or Biomica, developing drugs based on human microbiome, management and operation: Due to the unexpected medical condition of Dr. Elran Haber, Biomica’s CEO, Dr. Haber will cease acting as Biomica’s CEO and Mr. Ofer Haviv, Evogene’s President and Chief Executive Officer, will replace him, effective as of June 8, 2025. Evogene and Biomica express their gratitude to Dr. Haber for his valuable contributions to Biomica during his tenure and wish him good health. In addition, Biomica will significantly reduce its internal R&D activity, including a reduction in its headcount. Biomica will maintain the trials of its clinical phase I product BMC128, with the intention of identifying a third party for its continued development, as well as its other development programs. This change in Biomica's focus is in line with Evogene’s previously announced new plan, pursuant to which it intends to build a more capital-efficient and value-driven business model through the following two key priorities: generating cash flow and strategic value from its subsidiaries and unlocking the full potential of its ChemPass-AI tech-engine. Forward Looking Statements This Report of Foreign Private Issuer on Form 6-K, or this Form 6-K, contains “forward-looking statements” relating to future events. These statements may be identified by words such as “may”, “could”, “expects”, “hopes” “intends”, “anticipates”, “plans”, “believes”, “scheduled”, “estimates”, “demonstrates” or words of similar meaning. For example, Ev